Myriad loses appeal on cancer gene test patents
Wednesday, January 7, 2015 - 05:30
in Health & Medicine
US appeals court rules that biotechnology company cannot block competitor's breast cancer tests
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via